Illicit Benzodiazepine Overdose Trends Detected by Toxicology Investigators Consortium (ToxIC)
September 02, 2021 11:49 ET
|
American College of Medical Toxicology
Phoenix, AZ, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Data gathered by ToxIC’s Fentanyl Analog Study was reported in the CDC’s August 27, 2021 Morbidity and Mortality Weekly Report (MMWR) “Notes from the...
Meeting the Moment, Reflections One Year On: The American College of Medical Toxicology’s Response to the COVID-19 Pandemic
March 25, 2021 10:00 ET
|
American College of Medical Toxicology
Phoenix, AZ, March 25, 2021 (GLOBE NEWSWIRE) -- March 2021 marks the one-year anniversary of the World Health Organization’s official designation of the outbreak of the COVID-19 pandemic. The...
BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder
January 30, 2020 09:31 ET
|
BioCorRx Inc
ANAHEIM, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BioCorRx Provides 2019 Year-End Business Update
December 19, 2019 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
National Addiction Treatment Week Highlights the Critical Need for the Medical Community to Treat Addiction
October 21, 2019 08:39 ET
|
American Society of Addiction Medicine
Rockville, MD, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Each year, National Addiction Treatment Week (NATW) raises awareness that addiction is a disease, evidence-based treatments are available, and...
BioCorRx’s Director Louis Lucido Appeared Today on Yahoo Finance LIVE “On the Move”
July 22, 2019 14:03 ET
|
BioCorRx Inc
ANAHEIM, CA, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction...
BioCorRx to Present at the Planet MicroCap Showcase 2019 on May 1st in Las Vegas
April 30, 2019 09:50 ET
|
BioCorRx Inc
ANAHEIM, CA, April 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction...
BioCorRx’s Subsidiary, BioCorRx Pharmaceuticals, to Exhibit at ASAM 50th Annual Conference in Orlando, Florida
March 28, 2019 08:00 ET
|
BioCorRx Inc
ANAHEIM, CA, March 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company), a developer and provider of advanced solutions in the treatment of substance abuse...
BioCorRx Promotes Dr. Balbir S. Brar to Senior VP of Drug Development; Extends Service Agreement
March 27, 2019 07:37 ET
|
BioCorRx Inc
ANAHEIM, CA, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTC: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance abuse...
BioCorRx to Exhibit at the International Association of Chiefs of Police 2018 Annual Conference in Orlando, Florida
October 05, 2018 07:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid...